000972 *ST中基健康
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)115.426-261.98772.43531.706-87.099
总资产报酬率 ROA (%)-4.788-15.57410.5633.475-16.974
投入资产回报率 ROIC (%)-8.210-27.53421.38710.471-39.045

边际利润分析
销售毛利率 (%)-3.7554.98225.28126.2625.677
营业利润率 (%)-30.747-72.32815.3915.379-58.330
息税前利润/营业总收入 (%)-21.421-67.18922.3297.348-54.938
净利润/营业总收入 (%)-31.497-75.58018.9564.426-61.263

收益指标分析
经营活动净收益/利润总额(%)106.45229.94554.151332.74441.744
价值变动净收益/利润总额(%)0.0000.0000.000-0.0010.000
营业外收支净额/利润总额(%)-0.1724.19318.973-1.0254.788

偿债能力分析
流动比率 (X)0.7080.8060.8450.8980.766
速动比率 (X)0.1480.1750.1790.5350.422
资产负债率 (%)106.795100.98182.88987.83389.004
带息债务/全部投入资本 (%)98.44589.94069.83820.2347.178
股东权益/带息债务 (%)-11.840-3.22339.807168.210441.993
股东权益/负债合计 (%)-6.921-1.55820.06113.14811.505
利息保障倍数 (X)-2.310-8.0916.6973.631-8.685

营运能力分析
应收账款周转天数 (天)39.43449.96837.89468.460287.104
存货周转天数 (天)604.887983.536348.589156.409175.914